SERVICES*

Close-up TV News - Prolotheray lecture

Reversing Hypertension

Heavy Metals and all diseases

Close-Up TV News - Dr. Calapai's approach

News 12 Interview: Parkinson’s Disease, Glutathione and Chelation Therapy

News 12 Interview: Platelet-rich plasma therapy

Prolotherapy Interview News 12

News 12 Interview: Diabetes and Weight Loss
The Effect of Polyphenols in Olive Oil on Heart Disease Risk Factors *

Background:  Virgin olive oils are richer in phenolic content than refined olive oil. Small, randomized, crossover, controlled trials on the antioxidant effect of phenolic compounds from real-life daily doses of olive oil in humans have yielded conflicting results. Little information is available on the effect of the phenolic compounds of olive oil on plasma lipid levels. No international study with a large sample size has been done.

Objective:
To evaluate whether the phenolic content of olive oil further benefits plasma lipid levels and lipid oxidative damage compared with monounsaturated acid content.

Design: Randomized, crossover, controlled trial.

Setting: 6 research centers from 5 European countries.

Participants: 200 healthy male volunteers.

Measurements:
Glucose levels, plasma lipid levels, oxidative damage to lipid levels, and endogenous and exogenous antioxidants at baseline and before and after each intervention.

Intervention:
In a crossover study, participants were randomly assigned to 3 sequences of daily administration of 25 mL of 3 olive oils. Olive oils had low (2.7 mg/kg of olive oil), medium (164 mg/kg), or high (366 mg/kg) phenolic content but were otherwise similar. Intervention periods were 3 weeks preceded by 2-week washout periods.

Results: A linear increase in high-density lipoprotein (HDL) cholesterol levels was observed for low-, medium-, and high-polyphenol olive oil: mean change, 0.025 mmol/L (95% CI, 0.003 to 0.05 mmol/L), 0.032 mmol/L (CI, 0.005 to 0.05 mmol/L), and 0.045 mmol/L (CI, 0.02 to 0.06 mmol/L), respectively. Total cholesterol–HDL cholesterol ratio decreased linearly with the phenolic content of the olive oil. Triglyceride levels decreased by an average of 0.05 mmol/L for all olive oils. Oxidative stress markers decreased linearly with increasing phenolic content. Mean changes for oxidized low-density lipoprotein levels were 1.21 U/L (CI, –0.8 to 3.6 U/L), –1.48 U/L (–3.6 to 0.6 U/L), and –3.21 U/L (–5.1 to –0.8 U/L) for the low-, medium-, and high-polyphenol olive oil, respectively.

Limitations:
The olive oil may have interacted with other dietary components, participants' dietary intake was self-reported, and the intervention periods were short.

Conclusions: Olive oil is more than a monounsaturated fat. Its phenolic content can also provide benefits for plasma lipid levels and oxidative damage.

* Legal Disclaimer: Chelation and Hyperbaric Therapy, Stem Cell Therapy, and other treatments and modalities mentioned or referred to in this web site are medical techniques that may or may not be considered “mainstream”. As with any medical treatment, results will vary among individuals, and there is no implication or guarantee that you will heal or achieve the same outcome as patients herein.

As with any procedure, there could be pain or other substantial risks involved. These concerns should be discussed with your health care provider prior to any treatment so that you have proper informed consent and understand that there are no guarantees to healing.

THE INFORMATION IN THIS WEBSITE IS OFFERED FOR GENERAL EDUCATIONAL PURPOSES ONLY AND DOES NOT IMPLY OR GIVE MEDICAL ADVICE. No Doctor/Patient relationship shall be deemed to have arisen simply by reading the information contained on these pages, and you should consult with your personal physician/care giver regarding your medical treatment before undergoing any sort of treatment or therapy.

Published on 03-23-2009
Authors: Maria-Isabel Covas, MSc, PhD; Kristiina Nyyssonen, MSc, PhD; Henrik E. Poulsen, MD, PhD; Jari Kaikkonen, MSc, PhD; Hans-Joachim F. Zunft, MD, PhD; Holger Kiesewetter, MD, PhD; Antonio Gaddi, MD, PhD; Rafael de la Torre, MSc, PhD; Jaakko Mursu, MSc; Hans Baumler, MSc, PhD; Simona Nascetti, MD, PhD; Jukka T. Salonen, MD, PhD; Montserrat Fito, MD, PhD; Jyrki Virtanen, MSc; Jaume Marrugat, MD, PhD, for the EUROLIVE Study Group